This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cui, J. Articles by Hopper, J. L. Search for Related Content PubMed PubMed Citation Articles by Cui, J. Articles by Hopper, J. L.

Why Are the Majority of Hereditary Cases of Early-Onset Breast Cancer Sporadic? A Simulation Study¹

Centre for Genetic Epidemiology, The University of Melbourne, Carlton, Victoria 3053, Australia

Population-based studies, including those of Ashkenazi Jews, have observed that at least 50% of women with early-onset breast cancer who carry a germ line mutation in BRCA1 or BRCA2 do not report a family history of the disease. That is, the majority of "hereditary" cases are "sporadic." Furthermore, the great majority of "familial breast cancers" are not hereditary. We conducted a simulation study to evaluate the probability that a woman with early-onset breast cancer is a mutation carrier, given the number of affected relatives, for a range of plausible values of allele frequency (0.001–0.01), and increased risk in mutation carriers (5–20, equivalent to cumulative risks to age 70 of 25–70%, respectively, for Australian women). Families consisted of a case proband and her mother, sisters, and maternal and paternal grandmothers, and aunts. The numbers of sisters and aunts were generated according to Poisson distributions, and ages were assigned according to a Weibull distribution. The simulated distributions of family history and of the prevalence of mutation carriers among case probands were in general similar to those observed in population-based studies, although there was a suggestion of heterogeneity of breast cancer risk in mutation carriers. As is being observed empirically in population-based samples, a family history of breast cancer was not a strong predictor of mutation status; each affected female relative increased the risk of being a mutation carrier by only 2- to 3-fold. The probability of being a mutation carrier was generally low, except in families with extreme histories of breast cancer.

This article has been cited by other articles:

				C. B. Begg, R. W. Haile, A. Borg, K. E. Malone, P. Concannon, D. C. Thomas, B. Langholz, L. Bernstein, J. H. Olsen, C. F. Lynch, et al. Variation of Breast Cancer Risk Among BRCA1/2 Carriers JAMA, January 9, 2008; 299(2): 194 - 201. [Abstract] [Full Text] [PDF]

				J. Lorenzo Bermejo and K. Hemminki A population-based assessment of the clustering of breast cancer in families eligible for testing of BRCA1 and BRCA2 mutations Ann. Onc., February 1, 2005; 16(2): 322 - 329. [Abstract] [Full Text] [PDF]

				D. A. Hill, P. D. Inskip, W. R. Shapiro, R. G. Selker, H. A. Fine, P. M. Black, and M. S. Linet Cancer in First-Degree Relatives and Risk of Glioma in Adults Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1443 - 1448. [Abstract] [Full Text] [PDF]

				D. J. Kaufman, T. H. Beaty, and J. P. Struewing Segregation Analysis of 231 Ashkenazi Jewish Families for Evidence of Additional Breast Cancer Susceptibility Genes Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1045 - 1052. [Abstract] [Full Text] [PDF]